Australian Clinical Labs
ACL.AX
#6617
Rank
HK$3.68 B
Marketcap
HK$18.24
Share price
-0.85%
Change (1 day)
26.78%
Change (1 year)

Revenue for Australian Clinical Labs (ACL.AX)

Revenue in 2023: HK$3.59 B

According to Australian Clinical Labs's latest financial reports the company's current revenue (TTM) is HK$3.59 B. In 2023 the company made a revenue of HK$3.59 B a decrease over the revenue in the year 2022 that were of HK$5.33 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Australian Clinical Labs from 2021 to 2023

Annual revenue

Year Revenue Change
2023HK$3.59 B-32.57%
2022HK$5.33 B42.23%
2021HK$3.74 B